Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | NFE2L2 | Q16236 | 5/20 | 0.38 |
| ▸ | MANBA | O00462 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10090616 | 0.79 | LMNA (0.46) | LMNAMAPTL3MBTL1MANBATHRB | |
| SCHEMBL28150540 | 0.79 | LMNA (0.46) | LMNAMAPTL3MBTL1MANBATHRB | |
| SCHEMBL16939104 | 0.79 | LMNA (0.46) | LMNAMAPTL3MBTL1MANBATHRB | |
| SCHEMBL28150541 | 0.79 | LMNA (0.46) | LMNAMAPTL3MBTL1MANBATHRB | |
| SCHEMBL5903162 | 0.79 | LMNA (0.46) | LMNAMAPTL3MBTL1MANBATHRB | |
| SCHEMBL31387228 | 0.78 | LMNA (0.44) | LMNAMAPTL3MBTL1MANBATHRB | |
| SCHEMBL31075347 | 0.78 | LMNA (0.44) | LMNAMAPTL3MBTL1MANBATHRB | |
| SCHEMBL14097713 | 0.77 | LMNA (0.38) | LMNAMAPTL3MBTL1MANBATHRB | |
| SCHEMBL28436648 | 0.75 | LMNA (0.36) | LMNAMAPTL3MBTL1MANBATHRB | |
| SCHEMBL20101941 | 0.74 | NFE2L2 (0.40) | NFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150250169-A1 | ASCORBIC ACID-RELATED COMPOUND AND PLANT ANTIVIRAL AGENT | NIPPON SODA CO., LTD. (JP) | 2015-09-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150250169-A1 | ASCORBIC ACID-RELATED COMPOUND AND PLANT ANTIVIRAL AGENT | CBR3, OSR1, OXSR1 | LMNA 4569/4885MAPT 4717/4885L3MBTL1 2165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.